MMCAP Infuse Notice of RFP 33846 - Generic/Multisource Pharmaceuticals and Over the Counter Product

MMCAP Infuse, a governmental cooperative, is conducting a Request for Proposal (RFP) 33846 for multisource pharmaceutical and over-the-counter (OTC) products targeting state agencies and political subdivisions. The procurement seeks manufacturers and suppliers capable of providing generic pharmaceuticals and OTC products to be distributed through authorized pharmaceutical wholesalers. Vendors must submit comprehensive product proposals including detailed pricing information, administrative fee data, and communication protocols with authorized wholesalers. The RFP requires respondents to have contractual relationships with at least two of MMCAP Infuse's three authorized wholesalers and accept a mandatory 3% administrative fee. Evaluation criteria will focus on pricing structures, product formulations, packaging types, and member-specific preferences. The proposal submission deadline is March 8, 2024, with an anticipated contract effective date of July 1, 2024, and a potential contract term of up to four years. Vendors must provide unit costs, indicate EDI capabilities, specify bid types, and declare administrative fees through the ePro system.

The RFP does not explicitly outline specific set-aside designations or restrictions for disadvantaged enterprises. Current documentation does not indicate incumbent vendors or specific integration requirements with existing infrastructure. Vendors must meet comprehensive licensing, regulatory, and quality requirements, including providing monthly administrative fee reporting and maintaining appropriate intellectual property rights. The pricing structure allows for multiple approaches, including fixed pricing, non-fixed pricing, and wholesale acquisition cost (WAC) minus pricing. While specific award values are not explicitly stated, the scope suggests a significant multi-year contract serving thousands of state and local government facilities across the United States. Vendors must be prepared to provide justification for any proposed price increases and maintain competitive pricing throughout the contract term. The cooperative nature of the contract suggests potential for substantial pharmaceutical product procurement across multiple jurisdictions, including Oregon and its political subdivisions like Marion County and the city of Salem.